Company profile · free preview
LB Pharmaceuticals Inc Common Stock
LBRX · NASDAQ · Healthcare · Updated 10/18/2026
Revenue
—
Fiscal 2025
Net income
(25.2M)
Fiscal 2025
Free cash flow
(35.3M)
Fiscal 2025
Net cash / (debt)
—
Fiscal 2025
Five-year financials
| Fiscal year | 2025 |
|---|---|
| Revenue | — |
| Net income | (25.2M) |
| Diluted EPS | — |
| Operating cash flow | (35.2M) |
| Free cash flow | (35.3M) |
| Cash | $250.2M |
| Total debt | — |
SEC filings
No filings stored yet.
Ask anything about LB Pharmaceuticals Inc Common Stock's filings
"What changed since last year?" "Where is the cash going?" Get answers drawn straight from the filings.
Start researching freeMore companies
Palantir Technologies Inc. PLTRSiemens AG SIEGYSecuritize Corp. SECZNetflix, Inc. NFLXAvidia Bancorp, Inc. AVBCJoint Stock Company Kaspi.kz KSPITeucrium Soybean Fund SOYBD-Wave Quantum Inc. QBTSGreenland Mines Ltd. GRMLVolkswagen AG VWAGYGrupo Aeroportuario del Pacífico, S.A.B. de C.V. PACuniQure N.V. QUREVirtu Financial, Inc. VIRTLumexa Imaging Holdings, Inc. Common Stock LMRIAlliant Energy Corporation LNTRivian Automotive, Inc. RIVNQSR QSRKorsana Biosciences, Inc. KRSAUnited States Oil Fund, LP USOiShares Silver Trust SLVTesla, Inc. TSLAArm Holdings plc American Depositary Shares ARMAmbarella, Inc. AMBA